Expert Interview
Discussing botensilimab, a next-gen CTLA4 from Agenus, in combination with an anti-PD-1 in metastatic colorectal cancer (CRC)
Ticker(s): AGENInstitution: Advanced Care Oncology And Hematology Associates
- Medical Oncologist & Partner at ACOHA (private practice in New Jersey); fellowship trained at New York Presbyterian-Columbia University Medical Center.
- Manages ~400 patients with solid tumors and 25 patients with gastroesophageal junction cancer.
- Lectures widely on Gastrointestinal and Genitourinary malignancies.
Are You Interested In These Questions?
Slingshot Insights Explained
Expert research benefits investors by giving them timely access to unbiased real world perspectives on highly specialized topics. Slingshot Insights' crowdfunded model makes this access available at a fraction of the cost of other expert networks.
Reason
*Slingshot Insights provides access to information, not investment advice. We work to support you and facilitate access to experts; however we are not responsible for monitoring calls for the disclosure of MNPI. You should obtain financial, legal and tax advice from your qualified and licensed advisers before deciding to invest in any security.
